Literature DB >> 11026717

Primary osteosarcoma of a metatarsal bone.

E Y Lee1, L L Seeger, S D Nelson, J J Eckardt.   

Abstract

Although osteosarcoma is the most common primary bone malignancy of childhood and adolescence that is not related to marrow cells, involvement of the short tubular bones is uncommon. In contrast to more conventional sites, where the tumor is usually high grade and found in adolescents, osteosarcoma of the small bones is more likely to be low grade, and is often seen in older individuals. We present a case of low-grade primary osteosarcoma of a metatarsal bone in a 25-year-old woman.

Entities:  

Mesh:

Year:  2000        PMID: 11026717     DOI: 10.1007/s002560000237

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  5 in total

1.  Small cell osteosarcoma of a toe phalanx: a case report and review of literature.

Authors:  Jantine Posthumadeboer; Harm Ca Graat; Johannes Bras; Rachid Saouti
Journal:  J Orthop Surg Res       Date:  2010-06-03       Impact factor: 2.359

2.  Osteoblastoma-like Osteosarcoma of the Cuboid: A Case Report.

Authors:  Navin L Kumar; Andrew E Rosenberg; Kevin A Raskin
Journal:  J Orthop Surg Res       Date:  2010-08-06       Impact factor: 2.359

3.  Osteosarcoma of the hands and feet: a distinct clinico-pathological subgroup.

Authors:  Jakob K Anninga; Piero Picci; Marta Fiocco; Herman M J A Kroon; Daniel Vanel; Marco Alberghini; Hans Gelderblom; Pancras C W Hogendoorn
Journal:  Virchows Arch       Date:  2012-12-05       Impact factor: 4.064

4.  Imaging features of low-grade central osteosarcoma of the long bones and pelvis.

Authors:  Kelli J Andresen; Murali Sundaram; K Krishnan Unni; Franklin H Sim
Journal:  Skeletal Radiol       Date:  2004-06-03       Impact factor: 2.199

Review 5.  [Foot and ankle tumours : Part II: Malignant bone tumours and soft tissue tumours of the foot with differential diagnostic hints].

Authors:  T Grieser
Journal:  Radiologe       Date:  2018-05       Impact factor: 0.635

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.